In a Thursday post on the company blog, Alphabet Inc. subsidiary Google announced the launch of a new open-source neural network framework called SyntaxNet, along with a new English language parser -- Parsey McParseface -- which has been trained using SyntaxNet.
Announcing the launch of the SyntaxNet software programming toolkit and its Parsey McParseface natural language tool, Google said that the new products can now be distributed or modified by anyone for free.
The launch of SyntaxNet and its Parsey McParseface component underscores an apparent move by Google to democratize the tools used for developing apps which are powered by machine learning.
Describing Parsey McParseface as the world's most accurate model for parsing English, Google said that the free availability of the tool to developers would facilitate them in building apps which need to understand natural-language queries.
Expressing the hope that SyntaxNet open-source artificial-intelligence (AI) software system and Parsey McParseface computer program will be used effectively by developers, SyntaxNet's product manager Dave Orr said: "Our hope is that people will just use this instead of building their own. They don't have to reinvent the wheel."
Square Enix's 'Final Fantasy: Brave Exvius' role-playing game (RPG) for iOS and Android devices is set for launch in the West later this spring. The game was released in Japan in October 2015.
The Final Fantasy: Brave Exvius is a free-to-...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
China's Dakang Australia has been looking forward to sign a deal to buy Kidman, one of the Australia's biggest beef producers and owner of farm assets. However, the deal could be cancelled as the Australian government said it found that selling...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Google has officially released its Nexus Security Bulletin for the month of April. The bulletin...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
According to reports, two brand new Alfa Romeo Giulia...
On Thursday, a judge in Northern California District...
In a move which will facilitate app developers in...
On Thursday, a judge in Northern California District...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).